JI069

CAS No. 850019-35-1

JI069( —— )

Catalog No. M37038 CAS No. 850019-35-1

JI069 (WAY-354189) is a potent STAT3 inhibitor that inhibits gp130 signaling by inducing dissociation between gp130 and JAK1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 38 In Stock
10MG 57 In Stock
25MG 107 In Stock
50MG 172 In Stock
100MG 276 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    JI069
  • Note
    Research use only, not for human use.
  • Brief Description
    JI069 (WAY-354189) is a potent STAT3 inhibitor that inhibits gp130 signaling by inducing dissociation between gp130 and JAK1.
  • Description
    JI069 (WAY-354189) is a potent STAT3 inhibitor that inhibits gp130 signaling by inducing dissociation between gp130 and JAK1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    JAK/STAT Signaling
  • Target
    STAT
  • Recptor
    STAT | JAK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    850019-35-1
  • Formula Weight
    387.24
  • Molecular Formula
    C15H12Cl2N2O4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(N)C=1C=CSC1NC(=O)COC(=O)CC=2C(Cl)=CC=CC2Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Acetyl-trans-resvera...

    Acetyl-trans-resveratrol has anti-cancer activityit inhibits the phosphorylation of STAT3 and NFκB down-regulates Mcl-1 and up-regulates Bim and Puma in pancreatic cancer cells.

  • HO-3867

    A synthetic curcuminoid that selectively inhibits STAT3 phosphorylation, transcription, and DNA binding without affecting the expression of other active STATs.

  • Indirubin E804

    An indirubin derivative that potently blocks constitutive STAT3 signaling in human breast and prostate cancer cells.